Phage display for the generation of antibodies for proteome research, diagnostics and therapy

Molecules

Volumn 16, Issue 1, 2011, Pages 412-426

  Schirrmann, Thomas ^a   Meyer, Torsten ^a   Schütte, Mark ^a,b   Frenzel, André ^a   Hust, Michael ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

Antibody; Cancer; Diagnostics; Panning; Phage display; Proteome research; scFv

Indexed keywords

ANTIBODY; PROTEOME;

ARTICLE; AUTOMATION; BACTERIOPHAGE; DIAGNOSIS; GENETICS; HUMAN; IMMUNOLOGY; THERAPY;

ANTIBODIES; AUTOMATION; BACTERIOPHAGES; DIAGNOSIS; HUMANS; PROTEOME; THERAPEUTICS;

EID: 79251472471     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16010412     Document Type: Article

References (116)

1. von Behring, E.; Kitasato, S. Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren. Deut. Med. Wochenzeitschr. 1890, 16, 1113-1114.
2. Köhler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256, 495-497.
3. Winter, G.; Milstein, C. Man-made antibodies. Nature 1991, 349, 293-299.
4. Courtenay-Luck, N. S.; Epenetos, A. A.; Moore, R.; Larche, M.; Pectasides, D.; Dhokia, B.; Ritter, M. A. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res. 1986, 46, 6489-6493.
5. Tjandra, J. J.; Ramadi, L.; McKenzie, I. F. Development of human anti-murine antibody (HAMA) response in patients. Immunol. Cell Biol. 1990, 68, 367-376.
6. Almagro, J. C.; Fransson, J. Humanization of antibodies. Front. Biosci. 2008, 13, 1619-1633.
7. Hwang, W. Y. K.; Foote, J. Immunogenicity of engineered antibodies. Methods 2005, 36, 3-10.
8. Kashmiri, S. V. S.; De Pascalis, R.; Gonzales, N. R.; Schlom, J. SDR grafting-a new approach to antibody humanization. Methods 2005, 36, 25-34.
9. Studnicka, G. M.; Soares, S.; Better, M.; Williams, R. E.; Nadell, R.; Horwitz, A. H. Humanengineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues. Protein Eng. 1994, 7, 805-814.
10. Osbourn, J.; Groves, M.; Vaughan, T. From rodent reagents to human therapeutics using antibody guided selection. Methods 2005, 36, 61-68.
11. Fishwild, D. M.; O'Donnell, S. L.; Bengoechea, T.; Hudson, D. V.; Harding, F.; Bernhard, S. L.; Jones, D.; Kay, R. M.; Higgins, K. M.; Schramm, S. R.; Lonberg, N. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat. Biotechnol. 1996, 14, 845-851.
12. Jakobovits, A. Production of fully human antibodies by transgenic mice. Curr. Opin. Biotechnol. 1995, 6, 561-566.
13. Kuroiwa, Y.; Kasinathan, P.; Sathiyaseelan, T.; Jiao, J.; Matsushita, H.; Sathiyaseelan, J.; Wu, H.; Mellquist, J.; Hammitt, M.; Koster, J.; Kamoda, S.; Tachibana, K.; Ishida, I.; Robl, J. M. Antigenspecific human polyclonal antibodies from hyperimmunized cattle. Nat. Biotechnol. 2009, 27, 173-181.
14. Lonberg, N.; Huszar, D. Human antibodies from transgenic mice. Int. Rev. Immunol. 1995, 13, 65-93.
15. Weiner, L. M. Fully human therapeutic monoclonal antibodies. J. Immunother. 2006, 29, 1-9.
16. Huse, W. D.; Sastry, L.; Iverson, S. A.; Kang, A. S.; Alting-Mees, M.; Burton, D. R.; Benkovic, S. J.; Lerner, R. A. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989, 246, 1275-1281.
17. Persson, M. A.; Caothien, R. H.; Burton, D. R. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 2432-2436.
18. Smith, G. P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228, 1315-1317.
19. Breitling, F.; Dübel, S.; Seehaus, T.; Klewinghaus, I.; Little, M. A surface expression vector for antibody screening. Gene 1991, 104, 147-153.
20. McCafferty, J.; Griffiths, A. D.; Winter, G.; Chiswell, D. J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990, 348, 552-554.
21. Clackson, T.; Hoogenboom, H. R.; Griffiths, A. D.; Winter, G. Making antibody fragments using phage display libraries. Nature 1991, 352, 624-628.
22. Hoogenboom, H. R.; Griffiths, A. D.; Johnson, K. S.; Chiswell, D. J.; Hudson, P.; Winter, G. Multisubunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 1991, 19, 4133-4137.
23. Barbas, C. F.; Kang, A. S.; Lerner, R. A.; Benkovic, S. J. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 7978-7982.
24. Holt, L. J.; Herring, C.; Jespers, L. S.; Woolven, B. P.; Tomlinson, I. M. Domain antibodies: proteins for therapy. Trends Biotechnol. 2003, 21, 484-490.
25. Hoet, R. M.; Cohen, E. H.; Kent, R. B.; Rookey, K.; Schoonbroodt, S.; Hogan, S.; Rem, L.; Frans, N.; Daukandt, M.; Pieters, H.; van Hegelsom, R.; Neer, N. C.; Nastri, H. G.; Rondon, I. J.; Leeds, J. A.; Hufton, S. E.; Huang, L.; Kashin, I.; Devlin, M.; Kuang, G.; Steukers, M.; Viswanathan, M.; Nixon, A. E.; Sexton, D. J.; Hoogenboom, H. R.; Ladner, R. C. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity- determining-region diversity. Nat. Biotechnol. 2005, 23, 344-348.
26. Hust, M.; Dübel, S. Phage display vectors for the in vitro generation of human antibody fragments. Methods Mol. Biol. 2005, 295, 71-96.
27. Mazor, Y.; Van Blarcom, T.; Mabry, R.; Iverson, B. L.; Georgiou, G. Isolation of engineered, fulllength antibodies from libraries expressed in Escherichia coli. Nat. Biotechnol. 2007, 25, 563-565.
28. Simmons, L. C.; Reilly, D.; Klimowski, L.; Raju, T. S.; Meng, G.; Sims, P.; Hong, K.; Shields, R. L.; Damico, L. A.; Rancatore, P.; Yansura, D. G. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods 2002, 263, 133-147.
29. Parmley, S. F.; Smith, G. P. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 1988, 73, 305-318.
30. Hawlisch, H.; Müller, M.; Frank, R.; Bautsch, W.; Klos, A.; Köhl, J. Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets. Anal. Biochem. 2001, 293, 142-145.
31. Moghaddam, A.; Borgen, T.; Stacy, J.; Kausmally, L.; Simonsen, B.; Marvik, O. J.; Brekke, O. H.; Braunagel, M. Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine. J. Immunol. Methods 2003, 280, 139-155.
32. Hust, M.; Maiss, E.; Jacobsen, H.; Reinard, T. The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease. J. Virol. Methods 2002, 106, 225-233.
33. Hoogenboom, H. R. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 2005, 23, 1105-1116.
34. Hust, M.; Dübel, S.; Schirrmann, T. Selection of recombinant antibodies from antibody gene libraries. Methods Mol. Biol. 2007, 408, 243-255.
35. Winter, G.; Griffiths, A. D.; Hawkins, R. E.; Hoogenboom, H. R. Making antibodies by phage display technology. Annu. Rev. Immunol. 1994, 12, 433-455.
36. Buckler, D. R.; Park, A.; Viswanathan, M.; Hoet, R. M.; Ladner, R. C. Screening isolates from antibody phage-display libraries. Drug Discov. Today 2008, 13, 318-324.
37. Hallborn, J.; Carlsson, R. Automated screening procedure for high-throughput generation of antibody fragments. Biotechniques 2002, 30-37.
38. Konthur, Z.; Hust, M.; Dübel, S. Perspectives for systematic in vitro antibody generation. Gene 2005, 364, 19-29.
39. Schirrmann, T.; Al-Halabi, L.; Dübel, S.; Hust, M. Production systems for recombinant antibodies. Front. Biosci. 2008, 13, 4576-4594.
40. Hust, M.; Meyer, T.; Voedisch, B.; Rülker, T.; Thie, H.; El-Ghezal, A.; Kirsch, M. I.; Schütte, M.; Helmsing, S.; Meier, D.; Schirrmann, T.; Dübel, S. A human scFv antibody generation pipeline for proteome research. J. Biotechnol. 2011, In Press.
41. Thie, H.; Voedisch, B.; Dübel, S.; Hust, M.; Schirrmann, T. Affinity maturation by phage display. Methods Mol. Biol. 2009, 525, 309-322.
42. Kobayashi, N.; Oyama, H.; Kato, Y.; Goto, J.; Söderlind, E.; Borrebaeck, C. A. K. Two-step in vitro antibody affinity maturation enables estradiol-17beta assays with more than 10-fold higher sensitivity. Anal. Chem. 2010, 82, 1027-1038.
43. Finlay, W. J.; Cunningham, O.; Lambert, M. A.; Darmanin-Sheehan, A.; Liu, X.; Fennell, B. J.; Mahon, C. M.; Cummins, E.; Wade, J. M.; O'Sullivan, C. M.; Tan, X. Y.; Piche, N.; Pittman, D. D.; Paulsen, J.; Tchistiakova, L.; Kodangattil, S.; Gill, D.; Hufton, S. E. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions. J. Mol. Biol. 2009, 388, 541-558.
44. Pelat, T.; Hust, M.; Laffly, E.; Condemine, F.; Bottex, C.; Vidal, D.; Lefranc, M.; Dübel, S.; Thullier, P. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob. Agents Chemother. 2007, 51, 2758-2764.
45. Pelat, T.; Hust, M.; Hale, M.; Lefranc, M.; Dübel, S.; Thullier, P. Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol. 2009, 9, 60.
46. Sun, L.; Lu, X.; Li, C.; Wang, M.; Liu, Q.; Li, Z.; Hu, X.; Li, J.; Liu, F.; Li, Q.; Belser, J. A.; Hancock, K.; Shu, Y.; Katz, J. M.; Liang, M.; Li, D. Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PloS One 2009, 4, e5476.
47. Hust, M.; Dübel, S. Mating antibody phage display with proteomics. Trends Biotechnol. 2004, 22, 8-14.
48. de Haard, H. J.; van Neer, N.; Reurs, A.; Hufton, S. E.; Roovers, R. C.; Henderikx, P.; de Bruïne, A. P.; Arends, J. W.; Hoogenboom, H. R. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 1999, 274, 18218-18230.
49. Griffiths, A. D.; Williams, S. C.; Hartley, O.; Tomlinson, I. M.; Waterhouse, P.; Crosby, W. L.; Kontermann, R. E.; Jones, P. T.; Low, N. M.; Allison, T. J. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 1994, 13, 3245-3260.
50. Pini, A.; Viti, F.; Santucci, A.; Carnemolla, B.; Zardi, L.; Neri, P.; Neri, D. Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J. Biol. Chem. 1998, 273, 21769-21776.
51. Hayashi, N.; Welschof, M.; Zewe, M.; Braunagel, M.; Dübel, S.; Breitling, F.; Little, M. Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR. Biotechniques 1994, 17, 310-315.
52. Knappik, A.; Ge, L.; Honegger, A.; Pack, P.; Fischer, M.; Wellnhofer, G.; Hoess, A.; Wölle, J.; Plückthun, A.; Virnekäs, B. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 2000, 296, 57-86.
53. Sblattero, D.; Bradbury, A. Exploiting recombination in single bacteria to make large phage antibody libraries. Nat. Biotechnol. 2000, 18, 75-80.
54. Bittner, M.; Kupferer, P.; Morris, C. F. Electrophoretic transfer of proteins and nucleic acids from slab gels to diazobenzyloxymethyl cellulose or nitrocellulose sheets. Anal. Biochem. 1980, 102, 459-471.
55. Renart, J.; Reiser, J.; Stark, G. R. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc. Natl. Acad. Sci. U. S. A. 1979, 76, 3116-3120.
56. Engvall, E.; Perlmann, P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971, 8, 871-874.
57. Coons, A. H.; Creech, H. J.; Jones, R. N. Immunological properties of an antibody containing a fluorescence group. Proc. Soc. Exp. Biol. Med. 1941, 47, 200-202.
58. Bonner, W. A.; Hulett, H. R.; Sweet, R. G.; Herzenberg, L. A. Fluorescence activated cell sorting. Rev. Sci. Instrum. 1972, 43, 404-409.
59. Porter, R. R.; Press, E. M. Immunochemistry. Annu. Rev. Biochem. 1962, 31, 625-652.
60. Silzel, J. W.; Cercek, B.; Dodson, C.; Tsay, T.; Obremski, R. J. Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clin. Chem. 1998, 44, 2036-2043.
61. Stoevesandt, O.; Taussig, M. J.; He, M. Protein microarrays: high-throughput tools for proteomics. Expert Rev. Proteomics 2009, 6, 145-157.
62. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004, 431, 931-945.
63. Levy, S.; Sutton, G.; Ng, P. C.; Feuk, L.; Halpern, A. L.; Walenz, B. P.; Axelrod, N.; Huang, J.; Kirkness, E. F.; Denisov, G.; Lin, Y.; MacDonald, J. R.; Pang, A. W. C.; Shago, M.; Stockwell, T. B.; Tsiamouri, A.; Bafna, V.; Bansal, V.; Kravitz, S. A.; Busam, D. A.; Beeson, K. Y.; McIntosh, T. C.; Remington, K. A.; Abril, J. F.; Gill, J.; Borman, J.; Rogers, Y.; Frazier, M. E.; Scherer, S. W.; Strausberg, R. L.; Venter, J. C. The diploid genome sequence of an individual human. PLoS Biol. 2007, 5, e254.
64. Wheeler, D. A.; Srinivasan, M.; Egholm, M.; Shen, Y.; Chen, L.; McGuire, A.; He, W.; Chen, Y.; Makhijani, V.; Roth, G. T.; Gomes, X.; Tartaro, K.; Niazi, F.; Turcotte, C. L.; Irzyk, G. P.; Lupski, J. R.; Chinault, C.; Song, X.; Liu, Y.; Yuan, Y.; Nazareth, L.; Qin, X.; Muzny, D. M.; Margulies, M.; Weinstock, G. M.; Gibbs, R. A.; Rothberg, J. M. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008, 452, 872-876.
65. Harrison, P. M.; Kumar, A.; Lang, N.; Snyder, M.; Gerstein, M. A question of size: the eukaryotic proteome and the problems in defining it. Nucleic Acids Res. 2002, 30, 1083-1090.
66. Berglund, L.; Björling, E.; Oksvold, P.; Fagerberg, L.; Asplund, A.; Szigyarto, C. A.; Persson, A.; Ottosson, J.; Wernérus, H.; Nilsson, P.; Lundberg, E.; Sivertsson, A.; Navani, S.; Wester, K.; Kampf, C.; Hober, S.; Pontén, F.; Uhlén, M. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol. Cell. Proteomics 2008, 7, 2019-2027.
67. Dübel, S.; Stoevesandt, O.; Taussig, M. J.; Hust, M. Generating recombinant antibodies to the complete human proteome. Trends Biotechnol. 2010, 28, 333-339.
68. Taussig, M. J.; Stoevesandt, O.; Borrebaeck, C. A. K.; Bradbury, A. R.; Cahill, D.; Cambillau, C.; de Daruvar, A.; Dübel, S.; Eichler, J.; Frank, R.; Gibson, T. J.; Gloriam, D.; Gold, L.; Herberg, F. W.; Hermjakob, H.; Hoheisel, J. D.; Joos, T. O.; Kallioniemi, O.; Koegl, M.; Konthur, Z.; Korn, B.; Kremmer, E.; Krobitsch, S.; Landegren, U.; van der Maarel, S.; McCafferty, J.; Muyldermans, S.; Nygren, P.; Palcy, S.; Plückthun, A.; Polic, B.; Przybylski, M.; Saviranta, P.; Sawyer, A.; Sherman, D. J.; Skerra, A.; Templin, M.; Ueffing, M.; Uhlén, M. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 2007, 4, 13-17.
69. Wingren, C.; James, P.; Borrebaeck, C. A. K. Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics 2009, 9, 1511-1517.
70. Mersmann, M.; Meier, D.; Mersmann, J.; Helmsing, S.; Nilsson, P.; Gräslund, S.; Structural Genomics Consortium; Colwill, K.; Hust, M.; Dübel, S. Towards proteome scale antibody selections using phage display. New Biotechnol. 2010, 27, 118-128.
71. Pershad, K.; Pavlovic, J. D.; Gräslund, S.; Nilsson, P.; Colwill, K.; Karatt-Vellatt, A.; Schofield, D. J.; Dyson, M. R.; Pawson, T.; Kay, B. K.; McCafferty, J. Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display. Protein Eng. Des. Sel. 2010, 23, 279-288.
72. Björling, E.; Uhlén, M. Antibodypedia, a portal for sharing antibody and antigen validation data. Mol. Cell. Proteomics: MCP 2008, 7, 2028-2037.
73. Berglund, L.; Björling, E.; Oksvold, P.; Fagerberg, L.; Asplund, A.; Szigyarto, C. A.; Persson, A.; Ottosson, J.; Wernérus, H.; Nilsson, P.; Lundberg, E.; Sivertsson, A.; Navani, S.; Wester, K.; Kampf, C.; Hober, S.; Pontén, F.; Uhlén, M. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol. Cell. Proteomics 2008, 7, 2019-2027.
74. He, M.; Taussig, M. J. Selection of recombinant antibodies by eukaryotic ribosome display. Methods Mol. Biol. 2008, 484, 193-205.
75. Steiner, D.; Forrer, P.; Plückthun, A. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J. Mol. Biol. 2008, 382, 1211-1227.
76. Skerra, A. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities. FEBS J. 2008, 275, 2677-2683.
77. Dussart, P.; Petit, L.; Labeau, B.; Bremand, L.; Leduc, A.; Moua, D.; Matheus, S.; Baril, L. Evaluation of Two New Commercial Tests for the Diagnosis of Acute Dengue Virus Infection Using NS1 Antigen Detection in Human Serum. PLoS Negl. Trop. Dis. 2008, 2, e280.
78. Mergener, K.; Enzensberger, W.; Rübsamen-Waigmann, H.; von Briesen, H.; Doerr, H. W. Immunoglobulin class-and subclass-specific HIV antibody detection in serum and CSF specimens by ELISA and Western blot. Infection 1987, 15, 317-322.
79. Dong, L.; Masaki, Y.; Takegami, T.; Kawanami, T.; Itoh, K.; Jin, Z.; Huang, C.; Tong, X.; Fukushima, T.; Tanaka, M.; Sawaki, T.; Sakai, T.; Sugai, S.; Okazaki, T.; Hirose, Y.; Umehara, H. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen. Int. Immunol. 2007, 19, 331-336.
80. Abu Elzein, E. M.; Crowther, J. R. Enzyme-labelled immunosorbent assay techniques in foot-andmouth disease virus research. J. Hyg. 1978, 80, 391-399.
81. Molinelli, A.; Grossalber, K.; Führer, M.; Baumgartner, S.; Sulyok, M.; Krska, R. Development of qualitative and semiquantitative immunoassay-based rapid strip tests for the detection of T-2 toxin in wheat and oat. J. Agr. Food Chem. 2008, 56, 2589-2594.
82. Schweers, B. A.; Old, J.; Boonlayangoor, P. W.; Reich, K. A. Developmental validation of a novel lateral flow strip test for rapid identification of human blood (Rapid Stain Identification-Blood). Foren. Sci. Int. Genet. 2008, 2, 243-247.
83. Vignali, D. A. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 2000, 243, 243-255.
84. Sashihara, J.; Burbelo, P. D.; Savoldo, B.; Pierson, T. C.; Cohen, J. I. Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay. Virology 2009, 391, 249-256.
85. Marrack, J. R. Sensitivy and specificity of methods of detecting antibodies. Brit. Med. Bull. 1963, 19, 178-182.
86. Schlingemann, J.; Leijon, M.; Yacoub, A.; Schlingemann, H.; Zohari, S.; Matyi-Tóth, A.; Kiss, I.; Holmquist, G.; Nordengrahn, A.; Landegren, U.; Ekström, B.; Belák, S. Novel means of viral antigen identification: improved detection of avian influenza viruses by proximity ligation. J. Virol. Methods 2010, 163, 116-122.
87. Cai, J.; Liu, Z.; Wang, F.; Li, F. Phage display applications for molecular imaging. Curr. Pharm. Biotechnol. 2010, 11, 603-609.
88. Taussig, M. J. Bacteriophage linked assays for antibodies to protein antigens. Immunology 1970, 18, 323-330.
89. Gao, C.; Mao, S.; Lo, C. H.; Wirsching, P.; Lerner, R. A.; Janda, K. D. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays. Proc. Natl. Acad. Sci. U. S. A 1999, 96, 6025-6030.
90. Kirsch, M.; Hülseweh, B.; Nacke, C.; Rülker, T.; Schirrmann, T.; Marschall, H.; Hust, M.; Dübel, S. Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol. 2008, 8, 66.
91. Guo, Y.; Zhou, Y.; Zhang, X.; Zhang, Z.; Qiao, Y.; Bi, L.; Wen, J.; Liang, M.; Zhang, J. Phage display mediated immuno-PCR. Nucleic Acids Res. 2006, 34, e62.
92. Meyer, T.; Stratmann-Selke, J.; Meens, J.; Schirrmann, T.; Gerlach, G. F.; Frank, R.; Dübel, S.; Strutzberg-Minder, K.; Hust, M. Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium. Vet. Microbiol. 2011, 147, 162-169.
93. Pitaksajjakul, P.; Lekcharoensuk, P.; Upragarin, N.; Barbas, C. F.; Ibrahim, M. S.; Ikuta, K.; Ramasoota, P. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library. Biochem. Biophys. Res. Commun. 2010, 395, 496-501.
94. Schütte, M.; Thullier, P.; Pelat, T.; Wezler, X.; Rosenstock, P.; Hinz, D.; Kirsch, M. I.; Hasenberg, M.; Frank, R.; Schirrmann, T.; Gunzer, M.; Hust, M.; Dübel, S. Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PloS One 2009, 4, e6625.
95. Kügler, J.; Nieswandt, S.; Gerlach, G. F.; Meens, J.; Schirrmann, T.; Hust, M. Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display. Appl. Microbiol. Biotechnol. 2008, 80, 447-58.
96. Naseem, S.; Meens, J.; Jores, J.; Heller, M.; Dübel, S.; Hust, M.; Gerlach, G. Phage display-based identification and potential diagnostic application of novel antigens from Mycoplasma mycoides subsp. mycoides small colony type. Vet. Microbiol. 2010, 142, 285-292.
97. Miltiadou, D. R.; Mather, A.; Vilei, E. M.; Du Plessis, D. H. Identification of genes coding for B cell antigens of Mycoplasma mycoides subsp. mycoides Small Colony (MmmSC) by using phage display. BMC Microbiol. 2009, 9, 215.
98. Dübel, S. Recombinant therapeutic antibodies. Appl. Microbiol. Biotechnol. 2007, 74, 723-729.
99. Alonso-Ruiz, A.; Pijoan, J. I.; Ansuategui, E.; Urkaregi, A.; Calabozo, M.; Quintana, A. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet. Disord. 2008, 9, 52.
100. Peeters, M.; Price, T.; Van Laethem, J. Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? Oncologist 2009, 14, 29-39.
101. Chatenoud, L.; Bluestone, J. A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 2007, 7, 622-632.
102. Adams, G. P.; Weiner, L. M. Monoclonal antibody therapy of cancer. Nat. Biotechnol. 2005, 23, 1147-1157.
103. Moss, M. L.; Sklair-Tavron, L.; Nudelman, R. Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2008, 4, 300-309.
104. Dalle, S.; Thieblemont, C.; Thomas, L.; Dumontet, C. Monoclonal antibodies in clinical oncology. Anticancer Agents Med. Chem. 2008, 8, 523-532.
105. Jones, S. E. Metastatic breast cancer: the treatment challenge. Clin. Breast Cancer 2008, 8, 224-233.
106. Moroni, M.; Veronese, S.; Benvenuti, S.; Marrapese, G.; Sartore-Bianchi, A.; Di Nicolantonio, F.; Gambacorta, M.; Siena, S.; Bardelli, A. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol. 2005, 6, 279-286.
107. Kay, J.; Matteson, E. L.; Dasgupta, B.; Nash, P.; Durez, P.; Hall, S.; Hsia, E. C.; Han, J.; Wagner, C.; Xu, Z.; Visvanathan, S.; Rahman, M. U. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum. 2008, 58, 964-975.
108. Church, L. D.; McDermott, M. F. Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes. Expert Rev. Clin. Immunol. 2010, 6, 831-841.
109. Kavanaugh, A.; Menter, A.; Mendelsohn, A.; Shen, Y.; Lee, S.; Gottlieb, A. B. Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial. Curr. Med. Res. Opin. 2010, 26, 2385-2392.
110. Schirrmann, T.; Hust, M. Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol. Biol. 2010, 651, 177-209.
111. Thie, H.; Meyer, T.; Schirrmann, T.; Hust, M.; Dübel, S. Phage display derived therapeutic antibodies. Curr. Pharm. Biotechnol. 2008, 9, 439-446.
112. Vaughan, T. J.; Williams, A. J.; Pritchard, K.; Osbourn, J. K.; Pope, A. R.; Earnshaw, J. C.; McCafferty, J.; Hodits, R. A.; Wilton, J.; Johnson, K. S. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat. Biotechnol. 1996, 14, 309-314.
113. Baker, K. P.; Edwards, B. M.; Main, S. H.; Choi, G. H.; Wager, R. E.; Halpern, W. G.; Lappin, P. B.; Riccobene, T.; Abramian, D.; Sekut, L.; Sturm, B.; Poortman, C.; Minter, R. R.; Dobson, C. L.; Williams, E.; Carmen, S.; Smith, R.; Roschke, V.; Hilbert, D. M.; Vaughan, T. J.; Albert, V. R. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 2003, 48, 3253-3265.
114. Thie, H.; Toleikis, S.; Li, J.; von Wasielewsky, R.; Bastert, G.; Schirrmann, T.; Tourais Esteves, I.; Behrens, C. K.; Fournes, B.; Fournier, N.; de Romeuf, C.; Hust, M.; Dübel, S. Rise and fall of an anti-MUC1 specific antibody. PLoS One 2011, In Press.
115. Wallace, D. J.; Stohl, W.; Furie, R. A.; Lisse, J. R.; McKay, J. D.; Merrill, J. T.; Petri, M. A.; Ginzler, E. M.; Chatham, W. W.; McCune, W. J.; Fernandez, V.; Chevrier, M. R.; Zhong, Z. J.; Freimuth, W. W. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 2009, 61, 1168-1178.
116. Mazumdar, S. Raxibacumab. mAbs 2009, 1, 531-538.